Position in JNJ
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$54,701,516
+$12,226,064 QoQ
Shares Held
223,783
+9.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 35.068794323071906.ToString("F0")%
Shared 6.666279386727321.ToString("F0")%
None 58.26492629020078.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Savant Capital, LLC holds $182,516,970 across 15 Drug Manufacturers - General names. JNJ ranks #1 (30.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
223,783 | $54,701,516 | |
| 2 | LLY |
ELI LILLY & Co
|
52,081 | $47,902,541 | |
| 3 | ABBV |
AbbVie Inc.
|
163,461 | $35,551,132 | |
| 4 | MRK |
Merck & Co., Inc.
|
106,935 | $12,863,211 | |
| 5 | AMGN |
Amgen Inc
|
25,466 | $8,960,212 | |
| 6 | PFE |
Pfizer Inc
|
194,065 | $5,449,345 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
77,258 | $4,685,697 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
30,192 | $4,207,859 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,701,516 | 223,783 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $42,475,452 | 205,245 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $38,514,886 | 207,717 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $31,030,246 | 203,144 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $32,899,670 | 198,382 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $35,902,782 | 248,256 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $40,114,225 | 247,527 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $33,822,447 | 231,407 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $35,406,876 | 223,825 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $34,052,235 | 217,253 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $35,161,029 | 225,753 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $41,563,065 | 251,106 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $29,939,180 | 193,156 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $30,588,714 | 173,160 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,840,863 | 41,876 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $7,507,075 | 42,291 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $6,693,090 | 37,765 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $6,343,446 | 37,081 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,885,383 | 36,442 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,911,365 | 35,883 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $5,986,777 | 36,427 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $5,573,297 | 35,413 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $5,518,683 | 37,068 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $5,207,528 | 37,030 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,517,428 | 34,450 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||